Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
YH-25724 by Boehringer Ingelheim International for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Likelihood of Approval
YH-25724 is under clinical development by Boehringer Ingelheim International and currently in Phase I for Metabolic Dysfunction-Associated Steatotic Liver Disease...
YH-25724 by Boehringer Ingelheim International for Obesity: Likelihood of Approval
YH-25724 is under clinical development by Boehringer Ingelheim International and currently in Phase I for Obesity. According to GlobalData, Phase...
YH-25724 by Boehringer Ingelheim International for Obesity: Likelihood of Approval
YH-25724 is under clinical development by Boehringer Ingelheim International and currently in Phase I for Obesity. According to GlobalData, Phase...